...
首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >N-terminal pro-atrial natriuretic peptide as a biochemical marker of long-term interventional success after radiofrequency catheter ablation of paroxysmal supraventricular tachyarrhythmias.
【24h】

N-terminal pro-atrial natriuretic peptide as a biochemical marker of long-term interventional success after radiofrequency catheter ablation of paroxysmal supraventricular tachyarrhythmias.

机译:N端前房性利钠肽作为射频消融阵发性室上性快速性心律失常后长期介入治疗成功的生化指标。

获取原文
获取原文并翻译 | 示例

摘要

Radiofrequency (RF) catheter ablation has been shown to be highly effective in the treatment of supraventricular tachycardias. Atrial natriuretic peptide (ANP) and brain natriuretic peptide (B-type natriuretic peptide; BNP) are secreted by the heart mainly in response to myocardial stretch induced by volume load. The aim of the present study was to determine the time course of the N-terminal prohormone forms of ANP (NT-proANP) and BNP (NT-proBNP) in patients undergoing radiofrequency (RF) catheter ablation for paroxysmal supraventricular tachycardias. Serial blood samples were taken from 13 patients with symptomatic paroxysmal supraventricular tachycardias undergoing RF ablation and from 13 age- and gender-matched healthy controls. Blood was taken before ablation (day 0, baseline), and at day one and day 120 after ablation. Levels of NT-proANP were significantly higher before RF ablation (4862+/-726 pmol/l) as compared to day one (2021+/-220 pmol/l) and day 120 after RF ablation (2470+/-349 pmol/l) (with p<0.01 on day one and p<0.05 on day 120; n=13). The size of the left atrium decreased from 41.0+/-5.5 mm before ablation to 34.9+/-5.9 mm (n=13; p<0.05) on day 120 as measured by M-mode echocardiography. Levels of NT-proBNP showed comparable values before and on day one and day 120 after ablation and were not significantly elevated as compared to healthy controls. NT-proANP levels are increased in patients presenting with paroxysmal supraventricular tachycardias and decrease one day after radiofrequency catheter ablation, possibly reflecting a transient reduction of ANP secretion from injured myocardial cells. Lower NT-proANP levels in the long-term time course may result from reduction of atrial volume load and reconstitution of atrial architecture after successful treatment of supraventricular tachycardias. NT-proANP may serve as a useful laboratory marker to describe the long-term interventional success after RF ablation.
机译:射频(RF)导管消融已被证明在治疗室上性心动过速方面非常有效。心房利钠肽(ANP)和脑利钠肽(B型利钠肽; BNP)主要由心脏分泌,主要是由于容量负荷引起的心肌舒张。本研究的目的是确定阵发性室上性心动过速接受射频(RF)导管消融的患者中ANP(NT-proANP)和BNP(NT-proBNP)的N端激素形式的时程。从13例接受RF消融的症状性阵发性室上性心动过速患者以及13例年龄和性别相匹配的健康对照中抽取连续血样。在消融前(第0天,基线)以及消融后的第1天和第120天采血。与消融后第一天(2021 +/- 220 pmol / l)和消融后120天(2470 +/- 349 pmol / l)相比,消融前NT-proANP的水平(4862 +/- 726 pmol / l)显着更高l)(第一天的p <0.01,第120天的p <0.05; n = 13)。通过M型超声心动图测量,左心房大小从消融前的41.0 +/- 5.5 mm减少到第120天的34.9 +/- 5.9 mm(n = 13; p <0.05)。 NT-proBNP的水平在消融前,消融后的第1天,第1天和第120天显示可比的值,与健康对照组相比没有显着升高。阵发性室上性心动过速患者NT-proANP水平升高,射频导管消融后一天NT-proANP水平降低,这可能反映了受损心肌细胞中ANP分泌的短暂减少。长期治疗中较低的NT-proANP水平可能是由于成功治疗室上性心动过速后房室容积负荷减少和房室结构重建所致。 NT-proANP可作为描述射频消融后长期介入治疗成功的有用实验室标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号